Mentions
1
Across all reports
Quality Score
15/ 100
New
First Seen
May 25, 2026
Indexed in atlas
Last Seen
2h ago
Most recent reference
Positioning
Synthesized from 1 mention23andMe provides direct-to-consumer genetic testing for ancestry and health risk reports. It serves individuals curious about their genetic background and health predispositions. Its large consumer database and FDA-authorized health reports differentiate it from competitors. Customers pay a one-time fee for the test kit and can subscribe for ongoing health updates.
Strengths
4 cited- Large consumer genetic database
- FDA-authorized health risk reports
- Strong brand recognition
- Combines ancestry and health insights
Weaknesses
4 cited- Privacy concerns over genetic data
- Limited to consumer genomics
- Subscription needed for updates
- Narrow vertical focus
Recent mentions
Showing 1 of 1- incumbent2h ago
AI-Powered Personalized Health Risk Assessment Platform
poweredpersonalizedhealthriskassessmentplatform
Validate something like 23andMe
Use 23andMe as a starting point and let Unycorn map adjacent opportunities, underserved segments, and feature gaps worth pursuing.